CCN3 (NOV) Is a Negative Regulator of CCN2 (CTGF) and a Novel Endogenous Inhibitor of the Fibrotic Pathway in an in Vitro Model of Renal Disease
American Journal Of Pathology2009Vol. 174(5), pp. 1725–1734
Citations Over TimeTop 10% of 2009 papers
Bruce L. Riser, Feridoon Najmabadi, Bernard Perbal, Darryl R. Peterson, Jo Ann Rambow, M Riser, Ernest Sukowski, Herman Yeger, Sarah C. Riser
Related Papers
- → Inhibition of an endogenous growth‐related proteinase enhances the recovery of a negative growth regulator from cultured human cells.(1993)6 cited
- → Curcumin Functions as a Positive Regulator of miRNA Processing & a Negative Regulator of Cancer Stem Cell Proliferation(2010)1 cited
- → FGFR1 is a negative regulator of LINGO-1 expression in EAE (P2.194)(2015)
- → Supplementary Table Set S36-S39 from Comprehensive Genomic Analysis Identifies Novel Subtypes and Targets of Triple-Negative Breast Cancer(2023)
- → Supplementary Table Set S36-S39 from Comprehensive Genomic Analysis Identifies Novel Subtypes and Targets of Triple-Negative Breast Cancer(2023)